These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 36703939)
41. FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma. Yu Y; Wang Z; Zheng Q; Li J Aging (Albany NY); 2021 Mar; 13(6):8155-8176. PubMed ID: 33686947 [TBL] [Abstract][Full Text] [Related]
42. Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis. Zhu M; Zeng Q; Fan T; Lei Y; Wang F; Zheng S; Wang X; Zeng H; Tan F; Sun N; Xue Q; He J Front Immunol; 2022; 13():783495. PubMed ID: 35222371 [TBL] [Abstract][Full Text] [Related]
43. Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma. Cao K; Ling X; Jiang X; Ma J; Zhu J Respir Res; 2022 Nov; 23(1):306. PubMed ID: 36357897 [TBL] [Abstract][Full Text] [Related]
44. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis. Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150 [TBL] [Abstract][Full Text] [Related]
45. INHA acts as a novel and potential biomarker in lung adenocarcinoma and shapes the immune-suppressive tumor microenvironment. Zhang X; Zhang X; Jiang D; Zheng W; Wang H; Tian Y; Cheng B Transl Oncol; 2023 Jul; 33():101679. PubMed ID: 37105130 [TBL] [Abstract][Full Text] [Related]
46. Prognostic and Immune Infiltration Value of Proteasome Assembly Chaperone (PSMG) Family Genes in Lung Adenocarcinoma. Xuan DTM; Yeh IJ; Su CY; Liu HL; Ta HDK; Anuraga G; Chiao CC; Wang CY; Yen MC Int J Med Sci; 2023; 20(1):87-101. PubMed ID: 36619227 [TBL] [Abstract][Full Text] [Related]
47. Long Non-Coding RNA-TMPO-AS1 as ceRNA Binding to let-7c-5p Upregulates STRIP2 Expression and Predicts Poor Prognosis in Lung Adenocarcinoma. Wang J; Yuan Y; Tang L; Zhai H; Zhang D; Duan L; Jiang X; Li C Front Oncol; 2022; 12():921200. PubMed ID: 35774125 [TBL] [Abstract][Full Text] [Related]
48. [Identification and Analysis of SND1 as an Oncogene and Prognostic Biomarker for Lung Adenocarcinoma]. Zhang R; Huang H; Zhu G; Wu D; Chen C; Cao P; Ding C; Liu H; Chen J; Li Y Zhongguo Fei Ai Za Zhi; 2024 Jan; 27(1):25-37. PubMed ID: 38296623 [TBL] [Abstract][Full Text] [Related]
49. Elevated expression of Feng Z; Zhang J; Zheng Y; Wang Q; Min X; Tian T Per Med; 2021 Mar; 18(2):115-127. PubMed ID: 33576264 [No Abstract] [Full Text] [Related]
50. BOLA3 is a prognostic-related biomarker and correlated with immune infiltrates in lung adenocarcinoma. Wang XF; Lei W; Liu CM; Yang J; Zhu YH Int Immunopharmacol; 2022 Jun; 107():108652. PubMed ID: 35286914 [TBL] [Abstract][Full Text] [Related]
51. Construction of a Redox-Related Prognostic Model with Predictive Value in Survival and Therapeutic Response for Patients with Lung Adenocarcinoma. Xiao L; Li Q; Huang Y; Fan Z; Ma L; Liu B; Yuan X J Healthc Eng; 2022; 2022():7651758. PubMed ID: 35251577 [TBL] [Abstract][Full Text] [Related]
52. GALNT2/14 overexpression correlate with prognosis and methylation: potential therapeutic targets for lung adenocarcinoma. Yu Y; Wang Z; Zheng Q; Li J Gene; 2021 Jul; 790():145689. PubMed ID: 33964375 [TBL] [Abstract][Full Text] [Related]
53. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma. Li F; Ge D; Sun SL BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754 [TBL] [Abstract][Full Text] [Related]
54. Upregulation of POC1A in lung adenocarcinoma promotes tumour progression and predicts poor prognosis. Li ZH; Li JY; Wu ZT; Zhu YJ; Zhuo T; Nong JS; Qian J; Peng HJ; Dai L; Wang YY; Chen MW; Zeng XC J Cell Mol Med; 2024 Mar; 28(6):e18135. PubMed ID: 38429900 [TBL] [Abstract][Full Text] [Related]
55. Overexpression and diagnostic significance of INTS7 in lung adenocarcinoma and its effects on tumor microenvironment. Li X; Yao Y; Qian J; Jin G; Zeng G; Zhao H Int Immunopharmacol; 2021 Dec; 101(Pt B):108346. PubMed ID: 34781123 [TBL] [Abstract][Full Text] [Related]
56. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level. Wang W; Ren S; Wang Z; Zhang C; Huang J Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070 [TBL] [Abstract][Full Text] [Related]
57. Vesicle-mediated transport-related genes are prognostic predictors and are associated with tumor immunity in lung adenocarcinoma. Qian C; Jiang Z; Zhou T; Wu T; Zhang Y; Huang J; Ouyang J; Dong Z; Wu G; Cao J Front Immunol; 2022; 13():1034992. PubMed ID: 36524130 [TBL] [Abstract][Full Text] [Related]
58. The lncRNA ALMS1-IT1 may promote malignant progression of lung adenocarcinoma via AVL9-mediated activation of the cyclin-dependent kinase pathway. Luan T; Zhang TY; Lv ZH; Guan BX; Xu JY; Li J; Li MX; Hu SL FEBS Open Bio; 2021 May; 11(5):1504-1515. PubMed ID: 33683834 [TBL] [Abstract][Full Text] [Related]
59. High ubiquitin conjugating enzyme E2 T mRNA expression and its prognostic significance in lung adenocarcinoma: A study based on the TCGA database. Wu ZH; Zhang YJ; Sun HY Medicine (Baltimore); 2020 Jan; 99(4):e18543. PubMed ID: 31977847 [TBL] [Abstract][Full Text] [Related]
60. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma. Tian Q; Zhou Y; Zhu L; Gao H; Yang J Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]